Working at nuprobe provides me the opportunity to collaborate not only with my fellow scientists from nuprobe, but also with those from institutions and organizations across the globe. Nuprobe has used the blocker displacement amplification (bda) technology to create several proof of concept assays These assays demonstrate the capabilities and benefits of this technology, including its ability for more efficient use of sequencing capacity. By continuing to use this site, you accept our use of cookies Access news about breakthrough technologies in precision diagnostics and genomics led by the nuprobe team. Nuprobe announces new research and new product on dna microsatellite instability may 03 2021
Founded in 2016, nuprobe is a privately held company with facilities in houston, tx and china.
WATCH
